These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 12848813
1. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril. Seara FJ, Juanatey JR, Sande JL, Veloso PR, Reino AP, Román AV, Cerrato JC, Peña MG. Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813 [Abstract] [Full Text] [Related]
2. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR, García-Acuña JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, de la Peña MG. Am J Cardiol; 1998 Jan 15; 81(2):170-4. PubMed ID: 9591900 [Abstract] [Full Text] [Related]
3. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. González-Juanatey JR, Pose Reino A, García Acuña JM, Castelo Fuentes V, Amaro Gendón A, Calvo Gómez C, Gil de la Peña M. Eur Heart J; 1995 Dec 15; 16(12):1981-7. PubMed ID: 8682036 [Abstract] [Full Text] [Related]
5. Step-down of enalapril treatment for arterial hypertension. González-Juanatey JR, Reino AP, García-Acuña JM, González-Juanatey C, Valdes L, Cabezas-Cerrato J. Hypertension; 1999 Dec 15; 34(6):1287-92. PubMed ID: 10601132 [Abstract] [Full Text] [Related]
6. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA). Malmqvist K, Kahan T, Edner M, Bergfeldt L. Am J Cardiol; 2002 Nov 15; 90(10):1107-12. PubMed ID: 12423712 [Abstract] [Full Text] [Related]
9. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR, Pose Reino A, Román AV, García Acuña JM, Fernández López JA, Cerrato JC. Am J Cardiol; 1997 Feb 01; 79(3):373-6. PubMed ID: 9036764 [Abstract] [Full Text] [Related]
11. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy. Galetta F, Franzoni F, Magagna A, Femia FR, Pentimone F, Santoro G, Carpi A. Biomed Pharmacother; 2005 Feb 01; 59(1-2):15-9. PubMed ID: 15740930 [Abstract] [Full Text] [Related]
12. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus. Fogari R, Zoppi A, Maffioli P, Monti C, Lazzari P, Mugellini A, Derosa G. Diabetes Obes Metab; 2012 Apr 01; 14(4):341-7. PubMed ID: 22074122 [Abstract] [Full Text] [Related]
16. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Wachtell K, Dahlöf B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella JN, Devereux RB. Am Heart J; 2002 Dec 01; 144(6):1057-64. PubMed ID: 12486431 [Abstract] [Full Text] [Related]
18. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J. Int J Clin Pharmacol Ther; 1997 Jan 01; 35(1):38-42. PubMed ID: 9021441 [Abstract] [Full Text] [Related]
19. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. Angermann CE, Spes CH, Willems S, Dominiak P, Kemkes BM, Theisen K. Circulation; 1991 Aug 01; 84(2):583-93. PubMed ID: 1830519 [Abstract] [Full Text] [Related]